疏水相互作用层析分离重组人干扰素α2b

目的采用疏水相互作用层析分离重组人干扰素α2b,去除干扰素样品中的二聚体,得到高纯度的干扰素用于进一步的研究。方法首先采用阳离子交换层析纯化复性重组人干扰素α2b,去除了大部分的杂蛋白,然后采用疏水相互作用层析纯化重组人干扰素α2b,去除复性过程中产生的错误折叠体和二聚体,并考察盐浓度、pH值、流速和洗脱液中尿素对疏水相互作用层析纯化效果的影响。结果硫酸铵初始浓度1.2 mol/L、缓冲液pH值6.0、流速2.5 mL/min、洗脱液中添加尿素浓度为2 mol/L时疏水相互作用层析纯化效果最佳。最终得到的重组人干扰素α2b非还原型SDS-PAGE电泳均呈单一条带。结论确定了疏水层析纯化重组人干扰素α2b的最优条件,成功提取到具有高活性、高纯度的重组人干扰素α2b纯品。     

聚球藻PCC 7942氢酶的分离纯化及特性研究

报道了室温、空气环境下聚球藻Synechococcus sp.PCC7942氢酶的分离纯化.经过超声破碎、超速离心、离子交换层析、疏水层析及凝胶层析等步骤,氢酶被纯化了218倍,得率为6.5%,比活为1.46U·mg^-1蛋白.纯化氢酶的SDS-PAGE图显示五条蛋白带,分子量约为83kDa,60kDa,47kDa,30kDa和27kDa.该氢酶为可溶性的双向氢酶,其催化放氢的最佳电子供体为还原态的甲基紫精,最适温度50℃,最适pH8.0.     

芽孢杆菌O74碱性纤维素酶的纯化和性质研究

对芽孢杆菌(Bacillus)O74菌株产生的纤维素酶经过Sephadex G-100,DEAE-Sephadex A-25和疏水相互作用Agarose 4B三种层析方法,分离纯化到一个仅具有内切β-葡聚糖酶(CMC酶)活性的纯组分.提纯后酶的比活力提高了27.9倍,总回收率为40%.分子量和等电位点分别为52 500和4.1.酶在pH4-12范围内均具有较高活性.其最适反应温度为50℃,最适反应pH为7.0,属于反应pH范围较广泛的耐碱性纤维素酶.除Hg⁺,Ag⁺,Zn²⁺和Cu²⁺等少数离子及少数表面活性剂、助剂对酶活性有一定影响外,酶活性相当稳定,符合洗涤剂用酶的条件.     

重组人脑利钠肽的纯化与活性测定

目的:建立重组人脑利钠肽(BNP)的纯化方法,筛选疏水作用层析纯化介质并优化纯化条件。方法:根据带有6×His标签的Dsb A-BNP融合蛋白的特性,采用金属螯合亲和层析(IMAC)、凝血酶酶切去除His-Dsb A、阳离子交换层析等步骤进行粗纯;利用BNP的疏水性,分别选用不同疏水性质的介质Hi Trap Butyl FF、Hi Trap Phenyl(HS)及Source 15进行精纯;用SDS-PAGE和HPLC检测纯化获得的BNP的含量及纯度;用细胞法对BNP进行活性检测。结果:经IMAC、酶切去除标签蛋白及阳离子交换层析纯化后,获得纯度为60%的BNP;Hi Trap Butyl FF、Hi Trap Phenyl(HS)等疏水介质与BNP的吸附效果不佳,而经Source 15反相层析后,BNP的纯度可达98.98%,活性检测与对照品一致。结论:利用Source 15反相层析可获得高纯度、活性优的BNP原液,可满足后期制剂处方实验的要求,为后续研究奠定了基础。     

粗毛栓菌诱变菌株SAH-12漆酶的分离纯化及酶学性质研究

粗毛栓菌Trametes gallica诱变菌株SAH-12是通过紫外诱变选育所得的漆酶高产菌株,Active-PAGE分析表明SAH-12在高氮低碳无机盐培养液（LM3）中至少分泌3种漆酶同工酶（Lac1、Lac2、Lac3）。采用硫酸铵盐析、透析和Sephadex-G75分子筛层析从其培养液中分离纯化得到电泳纯的Lac1,纯化倍数6.54,酶活性回收59.7%。Lac1经SDS-PAGE验证为一条带,其表观分子量为61.5kDa。Lac1为一种糖蛋白,含糖量11.6%,等电点pI 4.40,催化氧化底物ABTS的最适反应温度为60℃,最适pH为2.6,Km值为25μmol/L。Lac1在40℃（pH4.0）以下和pH1.5～5.0（28℃）范围内稳定。金属离子Fe²⁺、Ag⁺、Hg²⁺和Cr³⁺与抑制剂DTT、SDS、EDTA和DMSO对Lac1有抑制作用,其中Fe²⁺和DTT完全抑制酶活,而Cu²⁺对酶有明显激活作用,Mn²⁺、Zn²⁺对酶活影响不大。Lac1不仅可使一些合成染料明显脱色,而且对苹果汁多酚祛除也有较好效果。40℃用该酶（1U/mL）处理苹果汁5h,其多酚含量可降低40%。     

粗毛栓菌诱变菌株SAH-12漆酶的分离纯化及酶学性质研究

粗毛栓菌Trametes gallica诱变菌株SAH-12是通过紫外诱变选育所得的漆酶高产菌株,Active-PAGE分析表明SAH-12在高氮低碳无机盐培养液（LM3）中至少分泌3种漆酶同工酶（Lac1、Lac2、Lac3）。采用硫酸铵盐析、透析和Sephadex-G75分子筛层析从其培养液中分离纯化得到电泳纯的Lac1,纯化倍数6.54,酶活性回收59.7%。Lac1经SDS-PAGE验证为一条带,其表观分子量为61.5kDa。Lac1为一种糖蛋白,含糖量11.6%,等电点pI 4.40,催化氧化底物ABTS的最适反应温度为60℃,最适pH为2.6,Km值为25μmol/L。Lac1在40℃（pH4.0）以下和pH1.5～5.0（28℃）范围内稳定。金属离子Fe²⁺、Ag⁺、Hg²⁺和Cr³⁺与抑制剂DTT、SDS、EDTA和DMSO对Lac1有抑制作用,其中Fe²⁺和DTT完全抑制酶活,而Cu²⁺对酶有明显激活作用,Mn²⁺、Zn²⁺对酶活影响不大。Lac1不仅可使一些合成染料明显脱色,而且对苹果汁多酚祛除也有较好效果。40℃用该酶（1U/mL）处理苹果汁5h,其多酚含量可降低40%。     

牛小脑肌醇磷脂激酶PI(4)K高产率纯化与特征

对牛小脑膜区肌醇磷脂激酶进行了11 500倍纯化,过程包括：TritonX-100抽提,硫酸铵沉淀,阳离子交换层析(phosphocellulose),亲和层析(Heparin Sepharose CL-6B)和阴离子交换层析(DEAE10,FPLC)等.纯化程度可达95％以上,对SDS-PAGE电泳结果进行扫描分析测其分子质量为56 ku.纯化的肌醇磷脂激酶的特异活性为450 nmol/mg·min, 动力学性质表现为ATP的表观K_m值为7.9×10^-7 mol/L,PI的表观K_m值为6.6×10^-7 mol/L. 腺嘌呤核苷是该酶的有效抑制剂,3.5×10^-7 mol/L腺嘌呤核苷可使该酶活力降低约50％,而TritonX-100对该酶活力具有刺激作用,0.5% TritonX-100可使该酶表现为最高活力.     

一步柱层析纯化螺旋藻藻蓝蛋白

采用硫酸铵盐析结合疏水层析技术分离纯化螺旋藻中的藻蓝蛋白.试验结果表明,在磷酸盐缓冲体系下藻蓝蛋白粗提液经1.25 mol/L硫酸铵盐析处理后离心脱气,只需采用一步Macro-Prep Methyl 疏水层析,藻蓝蛋白的纯度（A620/A280）可提高到4.017,回收率为19.38%.特征吸收峰和荧光光谱证实纯化后的产物符合藻蓝蛋白的性质,Native-PAGE电泳只出现单一染色带,表明纯化得到的藻蓝蛋白是均一的;SDS-PAGE电泳出现分子量为15.4 kDa、17.3 kDa的2条染色带,分别为藻蓝蛋白的α亚基与β亚基.     

限制性内切酶NotⅠ提纯的新工艺

目前有关限制性内切酶NotⅠ的性质特征及功能机制等方面的研究日渐增多,但商品化NotⅠ及某些限制性内切酶的价格依然居高不下,其主要原因在于表达量低、提纯程序繁琐、得率低等问题的存在。为探索限制性内切酶NotⅠ提纯的新工艺,从豚鼠耳炎诺卡菌(Nocardia otitidis-caviarum)中克隆出限制性内切酶NotⅠ的基因并使之在大肠杆菌中高效表达。首先将由成团肠杆菌(Enterobacter agglomerans)中克隆所得甲基化酶EagⅠM(EagⅠ methylase gene)基因连接到pBR322载体上,转化大肠杆菌ER2566,将豚鼠耳炎诺卡菌中克隆所得的限制性内切酶NotⅠR(NotⅠrestriction endonuclease gene)基因连接到表达载体pACYC184-PT₇上,将此重组质粒转化到上述已转入甲基化重组质粒pBR322-EagⅠM的ER2566中,构建成NotⅠ蛋白表达菌ER2566 。重组工程菌经IPTG诱导可表达限制性内切酶NotⅠ,并对诱导条件进行优化使之以可溶形式高效表达。应用KTA purifier 100蛋白纯化系统,对纯化工艺进行创新,通过DEAE Sephrose FF离子交换层析、phenyl HP疏水层析和Superdex 75 10/300 GL分子筛层析对蛋白进行提纯。纯化后NotⅠ经酶活力及纯度鉴定,其比活力为1.37×10⁶U/mg,提纯35倍,得率为17.8％,产量达9.8×10⁶ Units /g wet cell,提纯时间缩减为原来的1/10,在产量和效率上较以前报道均有很大提高。该纯化工艺的新方法,为实验室制备及工业化生产Ⅱ型限制性内切酶提供了进一步的借鉴。且该酶的成功获得为后续研究提供了材料,为更多新发现内切酶的成功克隆提供了参考。     

嗜热真菌Thermomyces lanuginosus A236热稳足葡萄糖淀粉酶的纯化及其特性

嗜热真菌Thermomyces lanuginosus A2a6在液体培养基中50℃下静止培养14天,粗提酶液经硫酸铵分级沉淀、DEAE-Toyopearl离子交换层析、Butyl-Toyopearl疏水层析、Sephacryl S100凝胶过滤和FPLC Mono Q离子交换层析,得到了凝胶电泳均质的葡萄糖淀粉酶。酶促反应产物经TLC分析为葡萄糖,证明纯化的酶为葡萄糖淀粉酶(EC 3．2．1.3)。SDS-PAGE测定其分子量为72,000,不具亚基,pI为4．0,富含val和Leu。酶反应最适温度和pH分别为70℃和5．0。在pH5．0条件下,酶在60℃保温lh,仍具有原酶活性。酶活性在70℃和80℃的半衰期分别为20min和6min, Ca²⁺对酶有激活作用,Fe³⁺、Al³⁺、Hg²⁺等金属离子对酶活力有一定的抑制作用。纯酶碳水化合物含量为12．4％。纯酶可水解可溶性淀粉,直链淀粉、支链淀粉．糊精、糖原、麦芽三糖和麦芽糖,其中可溶性淀粉为最适底物。     

Conformation and stability of two recombinant human interferon-alpha analogs

Structural features of a recombinant E. coli derived interferon-alpha analog, interferon consensus1, was studied by circular dichroism and fluorescence spectroscopy. Circular dichroic spectra of the purified protein showed that it has about 70% alpha-helix and a distinct tertiary structure. These structural features are similar to those for a natural interferon-alpha subtype, interferon-alpha 2, indicating that the amino acid substitutions in interferon consensus1 apparently did not alter the protein structure. Another analog, interferon consensus5, which has Ser instead of Cys at residues 1 and 99 but is otherwise identical to interferon consensus1, was prepared to study the role of the disulfide bond between Cys 1 and 99. Circular dichroic and fluorescence spectra indicated similarity in the structure of these two analogs. However, interferon consensus1 was significantly more stable than interferon consensus5 against denaturation. pH unfolding experiments indicated that the former protein is more stable in the transition region by about 1.6 kcal/mol, which was interpreted in terms of the increased free energy of the denatured state due to an extra disulfide bond in interferon consensus1.     

pH对毕赤酵母表达重组人复合a干扰素的降解影响

使用Pichia pastoris表达重组人复合a干扰素(cIFN)会发生降解、聚合等不均一表达的现象。在5 L发酵罐中考察了不同诱导pH对cIFN表达产生降解的影响, 结果发现在适合酵母生长的pH 3.0~7.0范围内, 当诱导pH为4.0~5.0时, cIFN不均一表达现象最少, 生物活性达到2.5×108 IU/mL。通过测定发酵液中总蛋白酶活和细胞活性寻找了cIFN降解出现的原因：发现低诱导pH下细胞死亡率升高释放更多酶系, 高诱导pH下蛋白酶活性明显增大, 两者都使蛋白酶作用加强, 加剧cIFN的降解; 特别是诱导pH为7.0时, 适宜的pH使蛋白酶酶活陡升, 将cIFN完全降解。     

pH对毕赤酵母表达重组人复合a干扰素的降解影响

使用Pichia pastoris表达重组人复合a干扰素(cIFN)会发生降解、聚合等不均一表达的现象。在5 L发酵罐中考察了不同诱导pH对cIFN表达产生降解的影响, 结果发现在适合酵母生长的pH 3.0~7.0范围内, 当诱导pH为4.0~5.0时, cIFN不均一表达现象最少, 生物活性达到2.5×108 IU/mL。通过测定发酵液中总蛋白酶活和细胞活性寻找了cIFN降解出现的原因：发现低诱导pH下细胞死亡率升高释放更多酶系, 高诱导pH下蛋白酶活性明显增大, 两者都使蛋白酶作用加强, 加剧cIFN的降解; 特别是诱导pH为7.0时, 适宜的pH使蛋白酶酶活陡升, 将cIFN完全降解。     

高效液相色谱法测定重组人干扰素α-2b注射液中乙二胺四乙酸二钠含量

目的:利用高效液相色谱(HPLC)法测定重组人干扰素α-2b注射液中EDTA二钠(乙二胺四乙酸二钠)的含量。方法:将EDTA二钠与氯化铁溶液于70℃水浴中反应20 min左右;色谱柱为SunFire C18(250 mm×4.6 mm,5μm,Waters),流动相为5%甲醇+95%0.64 g/L四丁基溴化铵和4.1 g/L三水合乙酸钠混合液,用冰乙酸调pH值至4.0,流速1 mL/min,检测波长254 nm。结果:该测定方法线性范围为0.025~0.5 g/L,线性关系良好(r=0.9997),加样回收率为98.27%(n=9,RSD=2.55%)。结论:本方法准确、快速、可靠,可用于重组人干扰素α-2b注射液中EDTA二钠含量的测定。     

Analysis of ribavirin mutagenicity in human hepatitis C virus infection

The addition of ribavirin to alpha interferon therapy significantly increases response rates for patients with chronic hepatitis C virus (HCV) infection, but ribavirin's antiviral mechanisms are unknown. Ribavirin has been suggested to have mutagenic potential in vitro that would lead to "error catastrophe," i.e., the generation of nonviable viral quasispecies due to the increment in the number of mutant genomes, which prevents the transmission of meaningful genetic information. We used extensive sequence-based analysis of two independent genomic regions in order to test in vivo the hypothesis that ribavirin administration accelerates the accumulation of mutations in the viral genome and that this acceleration occurs only when HCV replication is profoundly inhibited by coadministered alpha interferon. The rate of variation of the consensus sequence, the frequency of mutation, the error generation rate, and the between-sample genetic distance were measured for patients receiving ribavirin monotherapy, a combination of alpha interferon three times per week plus ribavirin, or a combination of alpha interferon daily plus ribavirin. Ribavirin monotherapy did not increase the rate of variation of the consensus sequence, the mutation frequency, the error generation rate, or the between-sample genetic distance. The accumulation of nucleotide substitutions did not accelerate, relative to the pretreatment period, during combination therapy with ribavirin and alpha interferon, even when viral replication was profoundly inhibited by alpha interferon. This study strongly undermines the hypothesis whereby ribavirin acts as an HCV mutagen in vivo.     

Effects of pH and flow rate on the release of 'bound' red cells from the splenic pulp.

On perfusion of isolated, denervated spleens with Ringer solution, immature and abnormal red cells are released into the venous outflow much more slowly than normal mature cells, being delayed through adherence to fine structures of the red pulp (Am. J. Physiol. 231, 1665-1671 (1976)). Evidence suggested that the rate at which such cells are released from the 'bound' state might depend on local pH and fluid shear rate within the pulp. Therefore, the rate of washout for this slow component of red cells, from cat spleens, was measured as a function of pH and flow rate of the perfusate. The volume of solution (V 1/2) for 50% washout of 'bound' cells decreased as pH was lowered from 7.8 to 6.6, especially (from 97 to 18 ml/g) between 7.4 and 6.6. The percentage total red cell outflow thus represented rose from 0.06 to 0.5 as pH fell from 7.8 to 6.6. At a high perfusion rate (14-16 ml/min) the V 1/2 value was only one-half that prevailing at a lower rate (4-6 ml/min), and the percentage flow of 'bound' red cells was more than three times greater. Both acidic pH and augmented blood flow thus assist release of adherent red cells from the splenic pulp.     

Continuous production of lactosucrose by immobilized Sterigmatomyces elviae mutant

In this study, in order to develop a continuous production process of lactosucrose in a packed-bed reactor, Sterigmatomyces elviae ATCC 18894 was selected and mutated. The mutant strain of S. elviae showed 54.3% higher lactosucrose production than the wild type. Reaction conditions such as temperature, pH, substrate concentration and flow rate were also optimized. Under optimized reaction conditions (50 degrees C, pH 6.0, 25% sucrose and 25% lactose as substrate, flow rate 1.2 ml/min), the maximum concentration of lactosucrose (192 g/l) was obtained. In a packed-bed reactor, continuous production of lactosucrose was performed using S. elviae mutant immobilized in calcium alginate, and about 180 g/l of lactosucrose production was achieved for 48 days.     

Rapid large-scale preparation of recombinant Erwinia chrysanthemi L-asparaginase.

L-asparaginase from Erwinia provides an alternative to the enzyme from E. coli for the effective treatment of acute lymphoblastic leukaemia. A procedure was required for the large-scale partial purification of the recombinant Erwinia enzyme cloned and expressed in Erwinia. Enzyme was extracted from Erwinia at high pH and extraneous protein precipitated at low pH. S-Sepharose FF was selected as the medium of choice for the chromatography step since it was adequate for the high flow rates required (linear flow rate 315 cm h-1) and the methylsulphonate functional groups exploited the high pI of the enzyme by allowing binding of L-asparaginase at pH 4.8 while most of the other proteins passed through the column. The useful capacity of the matrix was up to 34 mg enzyme/ml matrix at a linear flow rate of 95 cm h-1 and 15.4 mg enzyme/ml matrix at a linear flow rate of 315 cm h-1. Weakly bound protein was removed by a wash at pH 6.0. The L-asparaginase was eluted by a wash at pH 6.8 (linear flow rate 95 cm h-1) and was substantially pure, only requiring polishing steps to be suitable for use as a parenteral agent. The purity of the protein was complemented by a 92% recovery of active enzyme from this cation-exchange matrix.